Estrogen Receptor Beta Pipeline Report: Evaluates Market on Mechanism of Action (MoA), Drug Target, Route of Administration (RoA) and Molecule Type
Estrogen Receptor Beta - Pipeline Review, H1 2018, outlays comprehensive information on the Estrogen Receptor Beta targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA)
(EMAILWIRE.COM, April 03, 2018 ) Estrogen Receptor Beta (ER Beta or Nuclear Receptor Subfamily 3 Group A Member 2 or NR3A2 or ESR2) - Estrogen receptor beta (ERB) is a nuclear receptor that is activated by the sex hormone estrogen. It is encoded by the gene ESR2. Upon binding to 17beta-estradiol or related ligands, the encoded protein forms homo- or hetero-dimers that interact with specific DNA sequences to activate transcription.
Report Source: https://www.themarketreports.com/report/estrogen-receptor-beta-er-beta-or-nuclear-receptor-subfamily-3-group-a-member-2-or-nr3a2-or-esr2-pipeline-review-h1-2018
Scope
• The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
• The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
• The report reviews key players involved in Estrogen Receptor Beta targeted therapeutics and enlists all their major and minor projects
• The report assesses Estrogen Receptor Beta targeted therapeutics based on mechanism of action (MoA), route of administration (RoA) and molecule type
• The report summarizes all the dormant and discontinued pipeline projects
• The report reviews latest news and deals related to Estrogen Receptor Beta targeted therapeutics
Purchase this report at: https://www.themarketreports.com/report/buy-now/1022563
Companies Mentioned
• Acadia Pharmaceuticals Inc
• AstraZeneca Plc
• Atossa Genetics Inc
• Eagle Pharmaceuticals Inc
• Eli Lilly and Co
• Endece LLC
• EndoCeutics Inc
• Karo Pharma AB
• Kissei Pharmaceutical Co Ltd
• MEI Pharma Inc
• Mithra Pharmaceuticals SA
• Oasmia Pharmaceutical AB
Got a question; ask us at: https://www.themarketreports.com/report/ask-your-query/1022563
Report Source: https://www.themarketreports.com/report/estrogen-receptor-beta-er-beta-or-nuclear-receptor-subfamily-3-group-a-member-2-or-nr3a2-or-esr2-pipeline-review-h1-2018
Scope
• The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
• The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
• The report reviews key players involved in Estrogen Receptor Beta targeted therapeutics and enlists all their major and minor projects
• The report assesses Estrogen Receptor Beta targeted therapeutics based on mechanism of action (MoA), route of administration (RoA) and molecule type
• The report summarizes all the dormant and discontinued pipeline projects
• The report reviews latest news and deals related to Estrogen Receptor Beta targeted therapeutics
Purchase this report at: https://www.themarketreports.com/report/buy-now/1022563
Companies Mentioned
• Acadia Pharmaceuticals Inc
• AstraZeneca Plc
• Atossa Genetics Inc
• Eagle Pharmaceuticals Inc
• Eli Lilly and Co
• Endece LLC
• EndoCeutics Inc
• Karo Pharma AB
• Kissei Pharmaceutical Co Ltd
• MEI Pharma Inc
• Mithra Pharmaceuticals SA
• Oasmia Pharmaceutical AB
Got a question; ask us at: https://www.themarketreports.com/report/ask-your-query/1022563
Contact Information:
The Market Reports
Shirish Gupta
Tel: +1-631-407-1315
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
The Market Reports
Shirish Gupta
Tel: +1-631-407-1315
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results